AccessibilityHelp

Most Active Stocks Daily Stock Gainers Daily Stock Losers

Most Active Stocks Daily Stock Gainers Daily Stock Losers

Taylor Carmichael

XMFSaintCroix

Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.

Articles by Taylor Carmichael — Page 3

Nubank office 3

Jun 9, 2022 by Taylor Carmichael

Why Should You Follow Buffett Into This Bank Stock?

Nu is a new kind of bank (perhaps better described as a fintech), and it's taking South America by storm.

GettyImages-1352820340

Jun 7, 2022 by Taylor Carmichael

Ginkgo Bioworks Is Chasing a $4 Trillion Opportunity

You might want to make a small investment now, while the stock is trading under $4 a share.

GettyImages-949947128

Jun 4, 2022 by Taylor Carmichael, George Budwell, PhD, and Patrick Bafuma

3 Cathie Wood Stocks That Could Deliver Monster Returns

Here's why our roundtable likes 10x Genomics, Beam Therapeutics, and Recursion Pharmaceuticals.

GettyImages-842292368

May 31, 2022 by Taylor Carmichael, George Budwell, PhD, and Patrick Bafuma

3 Med-Tech Stocks With Incredible Potential

Here's why our roundtable likes iRhythm, SeaSpine Holdings, and Owlet.

GettyImages-155351397

May 25, 2022 by Taylor Carmichael

How Do You Stay Confident in a Market Crash?

Time is a great teacher.

Doctor Blight

May 21, 2022 by Taylor Carmichael

This Game Could Make Your Kids Rich One Day

All my crypto holdings are underwater, except for one -- the coolest game on the blockchain.

GettyImages-1251892822

May 21, 2022 by Taylor Carmichael, George Budwell, PhD, and Patrick Bafuma

3 Biotech Stocks With a Cash Pile Higher Than Their Valuations

Our roundtable found three biotechs with a nice cash cushion.

GettyImages-1343150662

May 15, 2022 by Taylor Carmichael

This Stock Is No. 1 on My Buy List

Digging into Appian's recent earnings report, I saw some amazing reasons to buy shares in 2022.

GettyImages-949947128

May 13, 2022 by Taylor Carmichael, George Budwell, PhD, and Patrick Bafuma

My Favorite Biotech

Here's why three Fool.com contributors love 10x Genomics, Axsome Therapeutics, and Doximity.

GettyImages-450806655

May 13, 2022 by Taylor Carmichael

10 Amazing Stocks Under $10

This bear market has crushed the stocks of some incredible early-stage companies. Here are 10 stocks that the market used to love and are now trading in the single digits.

GettyImages-108224060

May 13, 2022 by Taylor Carmichael

10 Amazing Stocks Under $10 (Part II)

Because of this stock market crash, some wonderful stocks are super cheap in 2022. Here's a mini-portfolio of innovative companies trading under $10 a share right now.

GettyImages-1278530606

May 9, 2022 by Taylor Carmichael, George Budwell, PhD, and Patrick Bafuma

3 Small-Caps That Might Be Acquisition Candidates

Here's why our roundtable thinks OptimizeRx, Affimed and Blueprint Medicines are all buys right now.

GettyImages-506712124

May 2, 2022 by Taylor Carmichael, George Budwell, PhD, and Patrick Bafuma

3 Healthcare Companies With Revenue Spiking 100% or More

Here's why three Fool.com contributors are bullish on Outset Medical, Aurinia Pharmaceuticals, and Shockwave Medical.

GettyImages-800433994

Apr 28, 2022 by Taylor Carmichael

4 Stocks That Could Turn $10,000 Into $200,000 by 2040

If you have a long investing time horizon, these strong performers could deliver massive gains.

GettyImages-1308866287

Apr 24, 2022 by Taylor Carmichael

The Risk/Reward for Opendoor Stock Is Amazing

While Opendoor might fail spectacularly in the iBuyer marketplace, the upside is so massive that a small investment in this small-cap makes sense.

GettyImages-1296010642

Apr 22, 2022 by Taylor Carmichael, George Budwell, PhD, and Patrick Bafuma

The FDA Will Soon Give These 3 Healthcare Companies the Green Light

These Fool.com contributors see happy news in the future for Novavax, Axsome Therapeutics, and Novocure.

GettyImages-618179988

Apr 20, 2022 by Taylor Carmichael

This Tiny Medical Device Will Make Billions of Dollars

Inspire Medical Systems is radically transforming how we treat sleep apnea.

GettyImages-501432924

Apr 18, 2022 by Taylor Carmichael, George Budwell, PhD, and Patrick Bafuma

The Safest Healthcare Stocks in the World

Stryker, Johnson & Johnson, and Intuitive Surgical can be counted on to be steady performers in your portfolio.

GettyImages-200398520-001

Apr 15, 2022 by Taylor Carmichael

3 Risky Stocks With Huge Potential Upside

Why risk-tolerant investors want to own Shopify, Silvergate Capital, and Pieris Pharmaceuticals.

GettyImages-635978124

Apr 9, 2022 by Taylor Carmichael and Keith Speights

These COVID Stocks Will Be Incredibly Profitable

As COVID-19 becomes endemic, what will the market look like for therapies and vaccines?

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services